Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Follistatin is an autocrine glycoprotein that acts as an antagonist to members of the TGF-β superfamily, particularly activin and myostatin. By binding to these ligands, follistatin prevents them from interacting with their receptors, modulating downstream signaling pathways. It plays a role in muscle growth and reproductive hormone release. Elevated levels may be associated with increased risk for certain diseases.
Sequesters ligands such as activins or myostatin, preventing their interaction with cell surface receptors.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Follistatin.